Magnus Jaderberg, CMO of Targovax, has presented at a symposium by The Royal Swedish Academy of Engineering Sciences

Magnus Jaderberg, Chief Medical Officer at Targovax, held an introductory presentation on immuno-oncology at The Royal Academy of Engineers conference on cancer medicine in Stockholm 16 May 2016. The title of the conference was “Nya cancerläkemedel för individanpassad behandling” (New cancer medicines for individualized treatment). Directed at a general public audience, the various presentations take the viewer step by step in an easy to understand way through the currently ongoing revolution of cancer treatment, which is brought about by new, innovative immuno-oncology medicines.

The video from the conference (in Swedish language only) is now available at: